Pharmaron (03759) announced that, in accordance with the company's director nomination policy, (i) Dr. Lou Boliang, Mr. Lou Xiaoqiang, and Ms. Zheng Bei have been nominated by shareholders as candidates for executive director; (ii) Ms. Wan Xuan has been nominated by shareholders as a candidate for non-executive director; and (iii) Ms. Li Lihua, Professor Zeng Jinfeng, and Ms. Shen Rong have been nominated as independent non-executive director candidates, recommended by the board's nomination committee and nominated by the board. According to the company's articles of association, the term for the third board of directors is three years. Following the completion of this term, Mr. Li Jiaqing and Mr. Yu Jian will not participate in the election for the fourth board of directors.